Buscar
Mostrando ítems 1-10 de 105
Falla cardíaca asociada con uso de imatinib mesilato: Reporte de un casoHeart failure associated to imatinib mesylate use. Case report.
(Sociedad Colombiana de Cardiología y Cirugía CardiovascularRehabilitación en SaludBogotá, Colombia, 2023)
Skin and oral lesions associated to imatinib mesylate therapy
(SPRINGER, 2009)
Imatinib mesylate is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) throughout all the phases of the disease. In most cases, this drug is well tolerated; however, some cases experience side effects. ...
Frequency of the BCR/ABL rearrangements and associated alterations detected by FISH during monitoring of patients taking imatinib mesylate in isolation
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2006-06-01)
A introdução do mesilato de imatinibe como tratamento da leucemia mielóide crônica tem salvado muitos pacientes, mas o sucesso da terapia tem sido prejudicado pela resistência e possível não destruição do clone maligno. ...
Frequency of the BCR/ABL rearrangements and associated alterations detected by FISH during monitoring of patients taking imatinib mesylate in isolation
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2006-06-01)
A introdução do mesilato de imatinibe como tratamento da leucemia mielóide crônica tem salvado muitos pacientes, mas o sucesso da terapia tem sido prejudicado pela resistência e possível não destruição do clone maligno. ...
Efecto de un inhibidor tirosina kinasa (imatinib) en pacientes con tumores estromales gastrointestinales metastásicos: Experiencia preliminar
(Sociedad Médica de Santiago, 2007)
Circulating microRNAs expression profile in newly diagnosed and imatinib treated chronic phase–chronic myeloid leukemia
(2018-01-01)
Chronic myeloid leukemia (CML) is a stem cell derived malignant disorder result of translocation t(9;22)(q34;q11) called Philadelphia chromosome (Ph+). microRNAS (miRNAs) are involved in several biological processes, ...
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice
(ELSEVIER SCIENCE BV, 2009)
Myofiber degeneration, inflammation, and fibrosis are remarkable features of Duchenne muscular dystrophy. We hypothesized that the administration of imatinib mesylate, an inhibitor of tyrosine kinase and TGF-beta pro-fibrogenic ...
Frequency of the BCR/ABL rearrangements and associated alterations detected by FISH during monitoring of patients taking imatinib mesylate in isolation
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2014)
Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients
(Wiley Blackwell Publishing, Inc, 2009-04)
Imatinib mesylate has proven to be the most effective treatment in chronic myeloid leukemia. Nevertheless, imatinib resistance has raised concern and prompted interest in additional strategies to achieve disease eradication. ...
Leucemia Mielóide Crônica em pediatria: perspectivas atuais
(Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2008-04-01)
Chronic myeloid leukemia (CML) is a rare event in childhood, comprising of less than 5% of all leukemia cases in this age group. CML is characterized by the presence of a specific molecular marker, the Ph+ chromosome, which ...